On November 10, 2014, altona Diagnostics GmbH received Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for the RealStar® Ebolavirus RT-PCR Kit 1.0.

altona Diagnostics GmbH recently added a real-time RT-PCR based assay for identification of the five Ebolavirus species and Marburgvirus to their product portfolio. Together with their already existing RealStar® Filovirus Screen RT-PCR Kit for first-line analysis, which is currently used in the epidemic epicenter in West-Africa by the European Mobile Laboratory, altona Diagnostics offers a comprehensive assay family for the detection and characterization of filovirus RNA from human sample material.